Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

Studies of patients with paraneoplastic neurologic disorders (PND) have revealed that apoptotic tumor serves as a potential potent trigger for the initiation of naturally occurring tumor immunity. The purpose of this study was to assess the feasibility, safety, and immunogenicity of an apoptotic tum...

Full description

Bibliographic Details
Main Authors: Mayu O Frank, Julia Kaufman, Suyan Tian, Mayte Suárez-Fariñas, Salina Parveen, Nathalie E Blachère, Michael J Morris, Susan Slovin, Howard I Scher, Matthew L Albert, Robert B Darnell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-09-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2931687?pdf=render

Internet

http://europepmc.org/articles/PMC2931687?pdf=render

Similar Items